These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2144921)

  • 21. A non-hemorrhagic hybrid heparin/heparan sulfate with anticoagulant potential.
    Brito AS; Cavalcante RS; Palhares LC; Hughes AJ; Andrade GP; Yates EA; Nader HB; Lima MA; Chavante SF
    Carbohydr Polym; 2014 Jan; 99():372-8. PubMed ID: 24274520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure and metabolism of rat liver heparan sulphate.
    Oldberg A; Höök M; Obrink B; Pertoft H; Rubin K
    Biochem J; 1977 Apr; 164(1):75-81. PubMed ID: 141928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder.
    Palmer RN; Rick ME; Rick PD; Zeller JA; Gralnick HR
    N Engl J Med; 1984 Jun; 310(26):1696-9. PubMed ID: 6233489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of antithrombin III isoforms by heparan sulphate glycosaminoglycans and other sulphated polysaccharides.
    Carlson TH; Kolman MR; Piepkorn M
    Blood Coagul Fibrinolysis; 1995 Jul; 6(5):474-80. PubMed ID: 8589216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in disaccharide composition of heparan sulphate fractions with increasing degrees of sulphation.
    Delaney SR; Conrad HE
    Biochem J; 1983 Feb; 209(2):315-22. PubMed ID: 6221718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel heparan sulphate with high degree of N-sulphation and high heparin cofactor-II activity from the brine shrimp Artemia franciscana.
    Chavante SF; Santos EA; Oliveira FW; Guerrini M; Torri G; Casu B; Dietrich CP; Nader HB
    Int J Biol Macromol; 2000 Mar; 27(1):49-57. PubMed ID: 10704986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in the distribution of O-sulphate groups of cell-surface and secreted heparan sulphate produced by human neuroblastoma cells in culture.
    Hampson IN; Kumar S; Gallagher JT
    Biochim Biophys Acta; 1983 Sep; 763(2):183-90. PubMed ID: 6225467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin affin regulatory peptide modulates the endogenous anticoagulant activity of heparin and heparan sulphate mimetics.
    Mejdoubi-Charef N; Courty J; Sineriz F; Papy-Garcia D; Charef S
    Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):296-302. PubMed ID: 22672269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of O-sulphate substituents on D-glucuronic acid units in heparin-related glycosaminoglycans using novel synthetic disaccharide standards.
    Razi N; Kreuger J; Lay L; Russo G; Panza L; Lindahl B; Lindahl U
    Glycobiology; 1995 Dec; 5(8):807-11. PubMed ID: 8720079
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparan sulphate/heparin glycosaminoglycans with strong affinity for the growth-promoter spermine have high antiproliferative activity.
    Belting M; Havsmark B; Jönsson M; Persson S; Fransson LA
    Glycobiology; 1996 Mar; 6(2):121-9. PubMed ID: 8727784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural requirements for heparan sulphate self-association.
    Fransson LA; Havsmark B
    Carbohydr Res; 1982 Nov; 110(1):135-44. PubMed ID: 6216949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosaminoglycans from marine clam Meretrix meretrix (Linne.) are an anticoagulant.
    Saravanan R; Vairamani S; Shanmugam A
    Prep Biochem Biotechnol; 2010; 40(4):305-15. PubMed ID: 21108134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbial heparin/heparan sulphate lyases: potential and applications.
    Tripathi CK; Banga J; Mishra V
    Appl Microbiol Biotechnol; 2012 Apr; 94(2):307-21. PubMed ID: 22391972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural studies on heparan sulphate from human lung fibroblasts. Characterization of oligosaccharides obtained by selective periodate oxidation of D-glucuronic acid residues followed by scission in alkali.
    Sjöberg I; Fransson LA
    Biochem J; 1980 Oct; 191(1):103-10. PubMed ID: 6258578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparan sulphates from porcine intestinal mucosa. Preparation and physicochemical properties.
    Johnson EA
    Thromb Res; 1984 Sep; 35(5):583-8. PubMed ID: 6237462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma.
    Horne MK; Chao ES; Wilson OJ; Scialla SJ; Lynch MA; Kragel PJ
    J Lab Clin Med; 1991 Sep; 118(3):250-60. PubMed ID: 1919298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-polymeric glycosaminoglycans in transformed cells. Transformation-dependent changes in the co-polymeric structure of heparan sulphate.
    Fransson LA; Havsmark B; Chiarugi VP
    Biochem J; 1982 Jan; 201(1):233-40. PubMed ID: 6282259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effect of heparin and heparan sulphate on two abnormal antithrombin III type 3 variants.
    Fischer AM; Beguin S; Sternberg C; Dautzenberg MD
    Br J Haematol; 1987 Jun; 66(2):213-7. PubMed ID: 2955807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dromedary glycosaminoglycans: molecular characterization of camel lung and liver heparan sulfate.
    Warda M; Linhardt RJ
    Comp Biochem Physiol B Biochem Mol Biol; 2006 Jan; 143(1):37-43. PubMed ID: 16298150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiangiogenic effect of sulphated and nonsulphated glycosaminoglycans and polysaccharides in the chick embryo chorioallantoic membrane.
    Hahnenberger R; Jakobson AM
    Glycoconj J; 1991 Aug; 8(4):350-3. PubMed ID: 1726778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.